Anticonvulsant, used to treat petit mal epilepsy. Adverse effects include blood abnormalities and gastrointestinal disturbances.
An anticonvulsant medication monitored in plasma to determine steady-state levels (reached 4-7 days after treatment is started).
An anticonvulsant drug used to treat petit mal epileptic fits. It is administered by mouth; side-effects such as drowsiness, depression, and digestive disturbances may occur but are usually temporary.
A drug used in the treatment of the form of epilepsy known as petit mal.
Ethosuximide is an anticonvulsant medication prescribed for the treatment of absence (petit mal) seizures. It may lead to side effects such as nausea and vomiting. In rare instances, it can impact the production of blood cells in the bone marrow.